JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chigorno, V.
Right arrow Articles by Sonnino, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chigorno, V.
Right arrow Articles by Sonnino, S.

Volume 271, Number 36, Issue of September 6, 1996 pp. 21738-21744
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Metabolic Processing of Gangliosides by Normal and Salla Human Fibroblasts in Culture
A STUDY PERFORMED BY ADMINISTERING RADIOACTIVE GM3 GANGLIOSIDE*

(Received for publication, February 21, 1996, and in revised form, May 28, 1996)

Vanna Chigorno , Guido Tettamanti and Sandro Sonnino Dagger

From the Study Center for the Functional Biochemistry of Brain Lipids, Department of Medical Chemistry and Biochemistry, The Medical School, University of Milan, Via Saldini 50, 20133 Milano, Italy

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

Cultured fibroblasts from normal subjects and from subjects affected by Salla disease, characterized by the lack or misfunction of the membrane carrier responsible for the egress of sialic acid from lysosomes, were fed with ganglioside GM3 labeled at the sialic acid acetyl group, [Neu5Ac-3H]GM3, or at C-3 of sphingosine (Sph), [Sph-3H]GM3, or at C-1 of stearoyl chain, [stearoyl-14C]GM3. After a 15-h pulse the total amount of cell-bound GM3 corresponded to about 2% of the endogenous ganglioside content. Cells were then subjected to a 72-h chase, and the radioactive products from both ganglioside catabolism and salvage processes of catabolic fragments were measured. These data indicated that about 50% of the cell-bound ganglioside underwent metabolic processing, suggesting a ganglioside half-life of 2-3 days. [Neu5Ac-3H] formed from [Neu5Ac-3H]GM3 degradation was mostly re-cycled for the biosynthesis of gangliosides and sialoglycoproteins, only a minor part being degraded to [3H]water, which constituted only 1.6% of total metabolite linked radioactivity. [Sph-3H] from the [Sph-3H]GM3 degradation was partly re-cycled for the biosynthesis of gangliosides, neutral glycosphingolipids and sphingomyelin, and partly (about 20% of the total metabolite linked radioactivity) degraded to [3H]water. In Salla fibroblasts metabolic processing of [Neu5Ac-3H]GM3 produced large amounts of free [3H]Neu5Ac, and a reduced incorporation of radioactivity into glycoconjugates (as compared to normal cells). However, the accumulation of free Neu5Ac was not accompanied by an increase of tritiated water. LacCer and Cer from [stearoyl-14C]GM3 catabolism were found to accumulate in Salla fibroblasts, an indication that the enzymes of glycosphingolipid metabolism were affected by the impairment of Neu5Ac egress from lysosomes. Particularly relevant was the accumulation of ceramide which was hardly detectable in control cells.


INTRODUCTION

Gangliosides, sialic acid containing glycosphingolipids that are normal components of the plasma membranes (1), are biosynthesized in the Golgi apparatus and degraded in the lysosomes (2). There is evidence that exogenously added gangliosides are taken up by the cells by endocytosis, degraded in the lysosomes, and the formed catabolites, of sugar and lipid nature, partly re-cycled for biosynthetic purposes (3, 4, 5). Little is known about the coordination between the flux of ganglioside degradation, linked to the endocytic vesicular flow, and the flux of ganglioside biosynthesis, linked to the exocytic flow. As well, little is known about the extent of metabolic re-cycling of the individual components of gangliosides produced during degradation, and the contribution of these salvage processes to the overall ganglioside turnover. The present work was undertaken with the aim of improving our knowledge of these events.

The experimental model we adopted consisted of cultured human skin fibroblasts fed with GM31,2 ganglioside isotopically labeled at the level of (a) sialic acid ([Neu5Ac-3H]GM3) providing information on sialic acid re-cycling, or (b) sphingosine ([Sph-3H]GM3) giving information on sphingosine re-cycling, or (c) fatty acid moiety ([stearoyl-14C]GM3), mainly informing on the ganglioside half-life. GM3 is known to be the main ganglioside of human fibroblasts (6).

In order to better acknowledge the impact of the coordination between the degradative and biosynthetic routes on the regular course of ganglioside turnover, we made a parallel study of the skin fibroblasts from patients suffering from Salla disease. In this rare inherited storage disorder (7) a gene mutation leads to the lack, or misfunction, of the membrane carrier responsible for the egress from lysosomes of sialic acid liberated during intralysosomal digestion. Since sialic acid in Salla fibroblasts accumulates in the lysosomes, it can be expected that its metabolic recycling is at least partially impaired.

The results obtained show that in fibroblasts: (a) the salvage of radioactive sialic acid produced by catabolism of [Neu5Ac-3H]GM3 is almost quantitative, this sugar being catabolized to tritiated water in very scant amount; (b) salvage of radioactive sphingosine produced by catabolism of [Sph-3H]GM3 is relevant, but part of the base is catabolized to tritiated water; (c) ganglioside metabolic half-life is 2-3 days, and (d) in Salla cells not only salvage processes of Neu5Ac are markedly lowered but overall ganglioside catabolism appears to be altered.


EXPERIMENTAL PROCEDURES

Materials

The commercial chemicals were the purest available, common solvents were distilled before use and deionized water, obtained by a Milli-Q system (Millipore), was distilled in a glass apparatus. Silica Gel 100 for column chromatography (0.063-0.2 mm, 70-230 mesh, ASTM) and high performance silica gel precoated thin-layer plates (HPTLC Kieselgel 60, 10 × 10 cm) were purchased from Merck GmbH (Darmstadt, Germany); Vibrio cholerae sialidase from Sigma; ceramide glycanase from Macrobdella decora from Boehringer Mannheim (Mannheim, Germany); sodium boro[3H]hydride (8 Ci/mmol), [3H]acetic anhydride (4.6 Ci/mol) and [1-14C]stearic acid (52 mCi/mmol) from Amersham International (Bucks, United Kingdom).

Preparation of Gangliosides, Lipids, and Radioactive Compounds

Ganglioside GM3 and GD3, extracted from bovine brain (8) and buttermilk (9), respectively, were purified to over 99% and characterized (8, 9). Lactosylceramide and glucosylceramide were prepared by partial acid hydrolysis of the total ganglioside mixture obtained from bovine brain (10). Ceramide was prepared from GM3 by treatment with ceramide glycanase (11) and sphingosine by alkaline hydrolysis of ceramide (11).

GM3 ganglioside was isotopically labeled with tritium at the level of sialic acid ([Neu5Ac-3H]GM3) or C-3 of sphingosine ([Sph-3H]GM3), or with 14C at the fatty acid moiety ([stearoyl-14C]GM3). [Neu5Ac-3H]GM3 was prepared by deacetylation of GM3 followed by N-acetylation with [3H]acetic anhydride (4, 8, 12). [stearoyl-14C]GM3 was prepared by deacylation of GM3 followed by N-acylation with [1-14C]stearic acid (8, 12). The preparation of [Sph-3H]GM3 was accomplished by perfecting (13) the dichlorodicyanobenzoquinone/sodium boro[3H]hydride and reversed phase high performance liquid chromatography purification procedures previously reported (14).

[Neu5Ac-3H]GM3, [Sph-3H]GM3, and [stearoyl-14C]GM3 were over 99.5% pure, as determined by digital radiochromatoscanning of HPTLC plates developed in three solvent systems (see below), and their specific radioactivity 2.3 Ci/mmol, 2.0 Ci/mmol, and 52.0 mCi/mmol, respectively.

Culture of Fibroblasts

Human skin fibroblasts were obtained by the punch technique. Normal cells were from young subjects and pathological cells from two boys who fulfilled the diagnostic criteria for Salla disease: psychomotor retardation, lysosomal storage demonstrated by electron microscopy in fresh skin biopsy specimens, and increased excretion of free sialic acid in the urine (7). The patients, diagnosed by Professor Martin Renlund (Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland) were: patient M., cell line 4 (Table I), is now 11 years old, has never learned to speak or walk, not even to crawl, and is severely spastic; patient L. J., cell line 5 (Table I), is now 18 years old, cannot walk or speak, and has severe spasticity.

Table I.

Ganglioside, protein, and DNA content in cultured normal and Salla fibroblasts

Gangliosides were extracted from three normal fibroblast lines (1, 2, and 3) and from two Salla fibroblast lines (4 and 5) (3 mg of cell proteins for each fibroblast line), purified, separated by HPTLC and quantified by densitometry. Ganglioside identification was achieved by chromatographic comparison with standard gangliosides. Protein and DNA content were determined harvesting and collecting cells, at confluency, from one 90-mm dish. All the data are mean ± S.D. of three experiments.
Component Normal
Salla
1 2 3 4 5

nmol/mg protein nmol/mg protein
Total gangliosides 3.3  ± 0.4 3.1  ± 0.3 3.7  ± 0.5 4.4  ± 0.5 3.7  ± 0.3
GM3 2.2  ± 0.2 2.6  ± 0.3 3.0  ± 0.4 3.8  ± 0.3 3.2  ± 0.3
GD3 1.1  ± 0.2 0.5  ± 0.1 0.7  ± 0.2 0.6  ± 0.2 0.5  ± 0.1
GM2, GM1, GD1a TR.a TR. TR. TR. TR.
Sphingomyelin 21.6  ± 3.5 NDb ND 15.9  ± 2.2 ND
µg/dish µg/dish
Protein 830  ± 150 790  ± 140 810  ± 145 650  ± 130 695  ± 140
µg/mg protein µg/mg protein
DNA 56  ± 3 ND ND 55  ± 3 ND

a  TR., traces.
b  ND, not determined.

Both pathological and normal cells were cultured and propagated as monolayers in 75-cm2 culture flasks at 37 °C in a humidified atmosphere containing 5% CO2, using Eagle's minimum essential medium supplemented with 10% FCS (15). Subcultures for experiments were made on 90-mm plastic Petri dishes and used at confluency.

Treatment of Cultured Fibroblasts with Radioactive Gangliosides

Radioactive GM3 ([Neu5Ac-3H]GM3, [Sph-3H]GM3, or [stearoyl-14C]GM3) dissolved in 1-propanol/water, 7:3 (v/v), was pipetted into a sterile tube, and dried under a nitrogen stream; the residue was then solubilized in an appropriate volume of pre-warmed (37 °C) Eagle's minimum essential medium to obtain a final ganglioside concentration of 4 × 10-7 M. We also carried out experiments using simultaneously equimolar amounts of [Neu5Ac-3H]GM3 and [stearoyl-14C]GM3, treated as above, to obtain a final ganglioside concentration of 8 × 10-7 M. Five ml of the ganglioside mixture were added to each culture dish, after accurate removal of the original culture medium. After a 15-h incubation (pulse), the radioactive medium was removed and the dishes were repeatedly washed first with Eagle's minimum essential medium solution, then with 10% FCS-containing medium (30 min) to remove ganglioside aggregates loosely bound to the cell surface, and finally incubated up to 3 days (chase) with 10 ml of fresh unlabeled 10% FCS/Eagle's minimum essential medium (4). At the end of the chase time the dishes were rinsed three times with Hank's solution, and the cells harvested in water (2 ml) by scraping with a rubber policemen. In some binding experiments with [Neu5Ac-3H]GM3 the cells were treated, before harvesting, with 2 ml of 0.1% trypsin in phosphate-buffered saline for 4 min to remove the small portion of gangliosides that strongly interacts with proteins protruding from the membrane surface (4).

Analysis of Cell Associated Radioactivity

The cell suspension was subjected to two cycles of freezing-thawing and then centrifuged at 100,000 × g for 30 min. A small portion of the supernatant was used for the analysis of free sialic acid and the remainder, as well as the pellet, was frozen and lyophilized. The residues were subjected to tetrahydrofuran/phosphate buffer lipid extraction and partition (16), resulting in a delipidized pellet, an organic phase, and an aqueous phase. HPTLC analyzes (see below) showed that about 15% of cell associated radioactive GM3 remained in the organic phase. Thus radioactive GM3 was quantified using both the aqueous and organic phases. Portions of the total lipid extract from cells treated with [stearoyl-14C]GM3 were subjected to alkaline hydrolysis to remove radioactive glycerolipids (17).

Portions of the delipidized pellet, prepared from cells incubated with [Neu5Ac-3H]GM3, were treated with V. cholerae sialidase (18) to remove sialic acid from sialoglycoproteins.

The radioactivity associated to total cells, sialic acid, proteins (delipidized pellet), and the organic and aqueous phases obtained by lipid extraction and fractionation, was determined by liquid scintillation counting. Radioactivity associated to individual lipids and free sialic acid, separated by HPTLC, was quantified by radiochromatoscanning (Digital Autoradiograph, Berthold, Germany) (11), and in some cases recognized by autoradiography or fluorography.

In the experiments making use of cells fed simultaneously with [Neu5Ac-3H]GM3 and [stearoyl-14C]GM3 the intramolecular distribution of radioactivity in formed GD3 was determined as follows. Radioactive GD3 was purified from the total ganglioside mixture extracted from 5 mg of cell proteins by silica gel column (12 × 1 cm) chromatography, using the solvent system chloroform/methanol/water, 60:35:5 (v/v), for both equilibration and elution. The purified GD3 was mixed with 50 µg of pure standard GD3 in a final volume of 0.1 ml of 50 mM sodium acetate buffer, pH 5.5, and subjected to partial enzymatic desialylation in the presence of 1 milliunit of V. cholerae sialidase (30 min, 37 °C). The hydrolysis products, GM3, LacCer, and Neu5Ac, together with residual GD3, were separated by HPTLC (see below), identified by radiochromatoscanning, scraped off, and analyzed for radioactivity content by liquid scintillation counting using a [3H/14C] dual-label program. In parallel HPTLC separations the hydrolysis products were identified by treatment with an anisaldehyde or p-dimethylaminobenzaldehyde spray reagents (see below), each spot being quantified by densitometry (19).

Analysis of Cell Medium Radioactivity

Total radioactivity present in the medium was determined by liquid scintillation counting. Tritiated water (20) formed during metabolic processing of the gangliosides was determined as follows. One ml of the cell culture medium was dialyzed overnight against 2 ml of water. The dialysis water (dialysate) was then divided into two portions. One portion was directly submitted to liquid scintillation counting, the other was completely dried at 36 °C and the residue dissolved with the same original amount of water and counted. The amount of tritiated water was determined by the difference in radioactivity content of the dialysate, before and after drying. In parallel experiments the dialysate was distilled at 100 °C and the distillation product, containing tritiated water, counted. Control experiments were performed by incubating [Sph-3H]GM3 or [Neu5Ac-3H]GM3 with the cell medium in the absence of cells.

Analytical Procedures

Monodimensional HPTLC was performed with the following solvent systems: (a) chloroform, methanol, 0.2% aqueous CaCl2, 50:42:11 (v/v), (b) chloroform/methanol/water, 110:40:6 (v/v), and (c) chloroform/methanol, 2:1 (v/v), to assess the homogeneity of radioactive GM3; chloroform/methanol, 2:1 (v/v), and after plate drying, chloroform/methanol, 0.2% aqueous CaCl2, 50:42:11 (v/v), to assess the aqueous phase composition (gangliosides) and to separate the products obtained by partial sialidase hydrolysis of GD3; chloroform/methanol, 2:1 (v/v), and, after plate drying, chloroform/methanol/water, 110:40:6 (v/v), to assess the composition of the organic phase (GM3, neutral sphingolipids, and sphingomyelin).

Two-dimensional HPTLC was performed for the following purposes and systems. To assess the occurrence of ceramide in the organic phase: 1st run, chloroform/methanol/water, 110:40:6 (v/v); 2nd run, ethyl acetate. To assess the occurrence of sphingosine in the organic phase: 1st run, chloroform/methanol/water, 110:40:6 (v/v); 2nd run, chloroform, methanol, 37% NH4OH, 40:10:1 (v/v). Colorimetric detection was carried out using the p-dimethylaminobenzaldehyde (21), the anisaldehyde (22), and the molybdate (23) spray reagents. Spot quantification was carried out by densitometry after HPTLC separation.

Gangliosides were assayed as bound Neu5Ac by the resorcinol-HCl method (24, 25), pure Neu5Ac being used as the reference standard. The protein content was determined (26) with bovine serum albumin as the reference standard. Proteins were analyzed by SDS-polyacrylamide gel electrophoresis (18). DNA was assayed according to Burton (27).


RESULTS

Ganglioside, Sphingomyelin, Protein, and DNA Content of Fibroblasts

Data on gangliosides, sphingomyelin, protein, and DNA content of cultured fibroblasts from three normal subjects and two Salla patients are shown in Table I. Fibroblasts, although displaying some variation from cell to cell line, contained GM3 as the major compound, followed by GD3, and traces of GM2, GM1, and GD1a. These results are in agreement with previous data (6).

The feeding experiments with [Neu5Ac-3H]GM3, [Sph-3H]GM3, and [stearoyl-14C]GM3 aimed to study ganglioside metabolic processing were performed using fibroblasts deriving from lines 1 (normal) and 4 (Salla) (Table I). Metabolic re-cycling of radioactive sialic acid was also studied in fibroblasts deriving from lines 2, 3, and 5 (Table I), fed with [Neu5Ac-3H]GM3.

Radioactivity Association to Fibroblasts and Release of Radioactivity in the Medium during Chase

The trend of radioactivity association to normal and Salla fibroblasts fed with [Neu5Ac-3H]GM3 is shown in Fig. 1. In both cell lines after 15 h exposure to 4 × 10-7 M radioactive GM3 followed by exhaustive washings with FCS free and FCS containing media, fairly measurable amounts of radioactivity resulted by association to fibroblasts (``serum-stable cell associated radioactivity''). A successive treatment with trypsin reduced the amount of cell associated radioactivity (``trypsin-stable cell associated radioactivity'') in either normal and Salla fibroblasts. This behavior is in agreement with previous findings (3, 4). In both fibroblast lines a substantial part of the cell associated radioactivity was released into the medium during chase. Released radioactivity was carried solely by GM3, with the exception of a portion of tritiated water. Both the serum- and the trypsin-stable associated radioactivity were markedly higher (40 and 60%, respectively) in Salla than in the normal fibroblasts.


Fig. 1. Behavior of fibroblast associated radioactivity during chase. Normal (A) and Salla fibroblasts (B) were fed with 4 × 10-7 M [Neu5Ac-3H]GM3 for 15 h and then subjected to chase in FCS containing medium. The data are the mean values of three experiments, with a S.D. never exceeding 15% of the mean values. ×, serum stable cell associated radioactivity; bullet , trypsin stable cell associated radioactivity; black-diamond , radioactivity in the medium.
[View Larger Version of this Image (14K GIF file)]

The release of radioactivity in the medium, rapid in the first day of chase and decreasing gradually thereafter, became almost zero after 3 days when the total associated radioactivity corresponded to about 3 and 4.8% of the total administered radioactivity in normal and Salla fibroblasts, respectively. Very similar results were obtained when the feeding experiments were performed with [Sph-3H]GM3.

Metabolic Processing of [Neu5Ac-3H]GM3

After fibroblast feeding with [Neu5Ac-3H]GM3 (15-h pulse plus 72-h chase), cell associated radioactivity was carried, besides GM3, by free sialic acid, the protein pellet (sialoglycoproteins), and GD3 ganglioside (Table II and Fig. 2), and in trace amounts by gangliosides chromatographically behaving as GM2, GM1, and GD1a. A very low amount of tritiated water was also found in the medium.

Table II.

Distribution of radioactivity in normal and Salla cultured fibroblasts fed with [Neu5Ac-3H]GM3, [Sph-3H]GM3, or [stearoyl-14C]GM3

The pulse time was 15 h and was followed by 72-h chase. The radioactivity linked to individual substances has been expressed as dpm/µg cell protein, and % of the total cell associated radioactivity plus, in the case of the experiments with [Neu5Ac-3H]GM3 and [Sph-3H]GM3, that carried by tritiated water in the medium. Results are referred to fibroblasts from cell lines numbers 1 (normal) and 4 (Salla) of Table I.
Compound [Neu5Ac-3H]GM3
[Sph-3H]GM3
[stearoyl-14C]GM3
Normal Salla Normal Salla Normal Salla

dpm/µg cell protein dpm/µg cell protein dpm/µg cell protein
GM3 277.3 552.2 247.6 501.7 3.77 7.35
GD3 64.5 56.2 22.5 24.0 0.04 0.03
LacCer 29.5 42.0 0.06 0.27
GlcCer 11.9 18.7 0.04 0.09
Cer 13.1 33.0 TR.a 0.28
SM 45.0 68.2 0.01 0.03
Glycoproteins 82.6 79.6
Neu5Ac 2.1 86.6
Sph TR. TR.
Water 3.4 5.4 40.2 62.2
Glycerolipids 3.25 7.45
Fatty acids 0.15 0.37
% of total dpm % of total dpm % of total dpm
GM3 64.5 70.8 60.4 66.9 52.6 49.1
GD3 15.0 7.2 5.5 3.2 0.5 0.2
LacCer 7.2 5.6 0.8 1.8
GlcCer 2.9 2.5 0.6 0.6
Cer 3.2 4.4 1.8
SM 11.0 9.1 0.2 0.2
Glycoproteins 19.2 10.2
Sph TR. TR.
Neu5Ac 0.5 11.1
Water 0.8 0.7 9.8 8.3
Glycerolipids 45.3 48.5
Fatty acids 2.1 2.4

a  TR., traces.


Fig. 2. Incorporation of radioactivity into sialic acid (A), sialoglycoproteins (B), and GD3 (C), after exposure of normal human fibroblasts, line 1 of Table I (solid line), and Salla fibroblasts, line 4 of Table I (dotted line), to 4 × 10-7 M [Neu5Ac-3H]GM3 for 15 h followed by chase up to 72 h. The data are the mean values of three experiments, with a S.D. never exceeding 15% of the mean values. S.D. at 72 h chase is not reported to show the results from cell lines 2 (square ), 3 (bullet ), and 5 (black-square) of Table I.
[View Larger Version of this Image (14K GIF file)]

In normal fibroblasts radioactive free sialic acid was hardly appreciable, in contrast with the impressive accumulation occurring in Salla fibroblasts (about 11% of total associated radioactivity). Conversely, the radioactivity carried by glycoproteins and GD3 in normal fibroblasts doubled that present in the Salla at all chase times (Fig. 2).

Metabolic Processing of [Sph-3H]GM3

After fibroblast feeding with [Sph-3H]GM3 (15-h pulse plus 72-h chase), cell associated radioactivity was carried, besides GM3, by LacCer, GlcCer, Cer, GD3, and SM (Table II). Radioactive sphingosine was detected in traces. Substantial amounts of tritiated water, the final catabolite from radioactive sphingosine, were also found in the medium (Table II). As shown in Figs. 3, A and C, and 4, A, C, and E, all the above 3H-metabolites markedly increased (as % of total associated radioactivity) during chase in fibroblasts. Remarkably, SM, GD3, LacCer, and GlcCer were much more abundant in normal than in Salla fibroblasts, whereas Cer prevailed in Salla fibroblasts.


Fig. 3. Incorporation of radioactivity into GD3 (A and B) and SM (C and D), after exposure of normal human fibroblasts (solid line) and Salla fibroblasts (dotted line) to 4 × 10-7 M [Sph-3H]GM3 (A and C) or [stearoyl-14C]GM3 (B and D) for 15 h followed by chase up to 72 h. The data are the mean values of three experiments, with a S.D. never exceeding 15% of the mean values.
[View Larger Version of this Image (17K GIF file)]


Fig. 4. Incorporation of radioactivity into LacCer (A and B), GlcCer (C and D), and Cer (E and F) after exposure of normal human fibroblasts (solid line) and Salla fibroblasts (dotted line) to 4 × 10-7 M [Sph3H]GM3 (A, C, and E) or [stearoyl-14C]GM3 (B, D, and F) for 15 h followed by chase. The data are the mean values of three experiments, with a standard deviation never exceeding 15% of the mean values.
[View Larger Version of this Image (16K GIF file)]

It should be noted that radioactive SM can be solely produced by a biosynthetic process which re-cycles radioactive sphingosine liberated during exogenous GM3 degradation (28, 29). Instead, radioactive LacCer, GlcCer, and Cer derive from two processes: catabolism of taken up and processed [Sph-3H]GM3 and biosynthesis by re-cycling of released sphingosine. The concomitant use of [stearoyl-14C]GM3 provides more precise evidence on this dual process.

Metabolic Processing of [stearoyl14C]GM3

After fibroblast feeding with [stearoyl-14C]GM3 (15-h pulse plus 72-h chase), cell associated radioactivity was carried, besides GM3, by glycerolipids, fatty acids, and in very small amounts, GD3, LacCer, GlcCer, Cer, and SM (Table II). Noteworthy, the proportion of radioactivity linked to glycerolipids was almost as high than that of GM3, indicating that the fatty acid liberated from GM3 degradation was massively re-cycled for the biosynthesis of glycerolipids. Instead the amount of radioactivity carried by LacCer, GlcCer, and Cer was very low, and, particularly very much lower than that carried by the same sphingolipids obtained after cell feeding with [Sph-3H]GM3. This difference indicates that with [stearoyl-14C]GM3, LacCer, GlcCer, and Cer result primarily from degradation and, by consequence, the substantially higher formation of these compounds observed with [Sph-3H]GM3 is substained by a process of biosynthesis by re-cycling of liberated sphingosine.

During chase (Figs. 3 and 4) the formation of radioactive GD3 and LacCer was higher in normal than in Salla fibroblasts, whereas ceramide, practically undetectable in normal cells, represented as much as 1.8% of total associated radioactivity in the pathological cells. Both SM and GlcCer were present in very small amounts in normal and pathological fibroblast lines.

Formation of Radioactive GD3 Studied by Simultaneous Administration of [Neu5Ac-3H]GM3 and [stearoyl-14C]GM3 to Cells

Radioactive GD3 was isolated from normal fibroblasts fed simultaneously with equimolar amounts of [Neu5Ac-3H]GM3 and [stearoyl-14C]GM3. After extraction and purification, radioactive GD3 was subjected to partial hydrolysis with V. cholerae sialidase and the resultant GM3, LacCer, and sialic acid, together with the remaining GD3, were analyzed for their [3H] and [14C] contents and specific radioactivity. Table III shows the results of these experiments. GD3 and GM3 carried both [3H] and [14C]; Neu5Ac carried only [3H] and LacCer only [14C], as expected. Released sialic acid and GM3 showed similar values of [3H] specific radioactivity, about half that of GD3. GD3, the released GM3, and LacCer had the same [14C] specific radioactivity and a low [14C] content.

Table III.

Incorporation of radioactivity into the two sialic acid units and into the fatty acyl moiety of GD3

Radioactive GD3 was extracted from cells fed simultaneously (15-h pulse plus 72-h chase) with [Neu5Ac-3H]GM3 (2.3 Ci/mmol) and [stearoyl-14C]GM3 (52 mCi/mmol), purified, mixed with standard nonlabeled GD3 and subjected to partial enzymatic hydrolysis with Vibrio cholerae sialidase, to obtain a mixture of GD3 (remainder), GM3, LacCer, and Neu5Ac. These compounds were separated by HPTLC and analyzed for mass or radioactivity content ([3H] S.D. ± 2%; [14C] S.D. ± 10%). Picomoles of labeled compound were calculated on the basis of starting ganglioside specific radioactivity. For details see ``Experimental Procedures.''
nmol of nonlabeled carrier GD3 [3H] [14C] [3H] [14C] [3H] [14C] [3H/14C]

dpm dpm/nmol nonlabeled carrier GD3 pmol of labeled compound pmol ratio
GD3 10.8 39,400 31 3,648 2.87 7.8 0.27 28.89
GM3 16.1 29,900 40 1,857 2.48 5.8 0.35 16.57
LacCer 7.2 0 21 0 2.91 0 0.18
Neu5Ac 30.0 54,850 0 1,828 0 10.8 0

If all the radioactive GD3 represents the direct sialylation of exogenous radioactive GM3 brought about by the recycling of catabolic radioactive Neu5Ac, partly diluted with nonradioactive Neu5Ac, then its [3H] content, in terms of starting picomoles of ganglioside, should be only slightly higher than the [14C] content. But if all the radioactive GD3 were the result of a neobiosynthetic process, then the amount of incorporated [3H] and [14C] would be related only to the extent of the [3H]Neu5Ac and [14C]stearic acid salvage processes and the dilution of the two catabolites in the nonlabeled corresponding compounds. Moreover the two Neu5Ac units must have the same specific radioactivity. Our results clearly show that the radioactive GD3 is mainly a product of neobiosynthesis. In fact, the [3H] content, in terms of picomoles, was much higher than the [14C] content, about 30 and 15 times in GD3 and GM3, respectively, and the two sialic acid units of GD3 had the same specific radioactivity. [3H]Neu5Ac is only slightly degraded, as proven by the very low amount of tritiated water found in the medium. This, together with the expected high dilution of [14C]stearic acid in the nonradioactive stearic acid, explains the wide difference in the incorporation of [3H] and [14C] in GD3.

Formation of Radioactive Proteins

The radioactivity found in the delipidized pellet from normal and Salla fibroblasts fed with [Neu5Ac-3H]GM3 was carried mainly by glycoproteins showing molecular mass of 70-180 kDa (revealed by SDS-polyacrylamide gel electrophoresis). Radioactivity was carried, almost completely, by the sialic acid of glycoproteins. In fact over 93% of this radioactivity was released from the delipidized pellet by treatment with sialidase and was found to be carried by free sialic acid. In the delipidized pellet from cells fed with [Sph-3H]GM3 or [stearoyl-14C]GM3 no radioactive proteins could be detected.


DISCUSSION

In the present work we explored the metabolic processing of exogenous gangliosides with the aim of verifying: (a) the extent of biosynthetic re-cycling of the individual components produced during ganglioside degradation, and (b) the contribution of these salvage processes to the overall ganglioside turnover. To this purpose, we employed cultured human fibroblasts fed with GM3 ganglioside, isotopically radiolabeled at the sialic acid acetyl group ([Neu5Ac-3H]GM3) or at C-3 of sphingosine ([Sph-3H]GM3) or at C-1 of the stearoyl chain ([stearoyl-14C]GM3. In comparison with normal lines we used fibroblast lines from subjects affected with Salla disease, where the egress of sialic acid from lysosomes is genetically impaired.

The molecular aspects of exogenous ganglioside-cell interactions and the modalities of ganglioside insertion of the cell surface and penetration into cells has been studied in detail (3, 4, 30, 31). The general view is that the major portion of exogenous gangliosides which bind to cells is loosely associated to the cell surface, and can be removed by rapid and repeated washings with protein containing solutions (albumin), owing to the easy formation of tight and stable lipoproteic complexes between gangliosides and proteins (32, 33). However, a minor but definite portion of ganglioside interacts strongly with proteins protruding from the membrane surface and can be released by mild trypsin treatment. Finally, a smaller portion of associated gangliosides is constituted by molecules that resist to trypsin treatment and appeared to be inserted into the membrane layer. This portion may be submitted to endocytosis (34). Our results introduce a new feature in this view. In fact, under our experimental conditions, we found that despite the rapid washing treatments with proteins, a portion of the cell associated GM3 continued to be released into the medium throughout the chase period. The time course of this release followed a hyperbolic trend and reached a constant value after about 72 h chase. This suggests that a portion of the total cell associated gangliosides interacts with the cell surface differently from that easily removed by treatment with protein containing media. Of course, the portion of GM3 that is released into the medium during chase does not undergo internalization into cells and is not available to metabolic processing.

Considering (a) the specific radioactivity of [3H]GM3 ([Neu5Ac-3H]GM3 or [Sph-3H]GM3 were used to this purpose), (b) the total cell associated radioactivity from which was subtracted the radioactivity released as GM3 in the medium in the considered period of chase, and (c) the amount of tritiated water found in the medium in the same chase period, we calculated that about 79 pmol/mg protein of exogenous GM3 available to endocytosis and metabolic processing were taken up by normal cells. This amount constituted only 2.3% of the cell ganglioside content. This small change in the ganglioside membrane content should not prevent exogenous ganglioside to distribute throughout the cell membrane and to follow the routes of internalization into cells and intracellular metabolization of the endogenous gangliosides.

GM3 taken up by the cells was subjected to degradation and the catabolic fragments were re-cycled for biosynthetic purposes (salvage processes). Particularly, the salvage processes of Neu5Ac, sphingosine, and stearic acid were followed.

The catabolism of [Neu5Ac-3H]GM3 produced free radioactive sialic acid that was used for the biosynthesis of sialoglycoproteins and gangliosides (namely GD3). The presence of radioactive sialic acid in cell glycoproteins, contained in the protein pellet, is direct evidence of sialic acid re-cycling. A similar direct conclusion is not necessarily valid for the radioactive sialic acid present in GD3. In fact, it cannot be excluded that a portion of formed radioactive GD3 derives from a process of direct GM3 sialylation assuming that endocytosed GM3, besides being routed to lysosomes, can directly reach the Golgi apparatus (35). In order to verify this possibility we analyzed the radioactivity distribution in the dual-labeled GD3 formed after simultaneous cell feeding with [Neu5Ac-3H]GM3 and [stearoyl-14C]GM3 (Table III). The finding that the two sialic acid residues present in GD3 have the same 3H-specific radioactivity and that GD3 incorporates much more [3H]Neu5Ac than [14C]stearic acid strongly supports the notion that the formed radioactive GD3 is mainly a product of biosynthesis brought about by re-cycling of [3H]Neu5Ac obtained from [Neu5Ac-3H]GM3 degradation.

The salvage of Neu5Ac is a very important process in fibroblasts. In fact, in normal fibroblasts fed with [Neu5Ac-3H]GM3, 15 h pulse plus 72 h chase, almost all the radioactive sialic acid produced from catabolism of [Neu5Ac-3H]GM3 was re-cycled; in all the three cell lines (Table I, Fig. 2) only a very minor portion remained free in the cells or was degraded to radioactive water, the final catabolite of radioactive sialic acid degradation.

Salvage of sphingosine was also high, and after the administration of [Sph-3H]GM3 [3H]Sph was found in biosynthesized gangliosides and sphingomyelin. Free radioactive sphingosine was hardly detectable in total cell extracts but its catabolism to tritiated water was quite marked.

The catabolism of gangliosides occurs in the lysosomes. It is known that Neu5Ac leaves lysosomes through a membrane protein mediated process. No information on the exit of sphingosine from the lysosomes is available. However, we do know that sphingosine must leave the lysosomes to reach the endoplasmatic reticulum and Golgi apparatus where it is involved in sphingolipid biosynthesis. Thus knowledge of the exit process is of crucial importance also in view of the suggested involvement of sphingosine as a metabolic bioregulator (36).

Radioactive fatty acids from the catabolism of [stearoyl-14C]GM3 were also re-used for sphingolipid biosynthesis, but only to a very small extent. In other words, the occurrence of salvage of stearic acid for ganglioside biosynthesis is a very minor phenomenom, if any. This is due to the dilution of the radioactive stearic acid in the cell fatty acid pool, and to the fact that stearic acid is a minor component of fibroblast gangliosides, which mainly contain C-22 and C-24 acyl chains. However, the fatty acid liberated from GM3 degradation is largely re-cycled for the biosynthesis of glycerolipids. In normal fibroblats after 72 h chase with [stearoyl-14C]GM3 close to 45% of the total cell associated radioactivity was carried by glycerophospholipids and about 50% by GM3. Since neobiosynthesis of GM3 from stearic acid is virtually absent at the end of the chase period, by the use of [stearoyl-14C]GM3 it can be established that after 3 days of chase 50% of radioactive GM3 was constituted by no yet processed exogenous GM3.

The administration of radioactive glucose (6) or glucosamine (37), to fibroblast cells, yielded GM3 and GD3 with similar specific radioactivity at long chase. Similarly, in a study on rat brain gangliosides (38), intracranial administration of radioactive N-acetylmannosamine yielded a mixture of gangliosides all of which showed the same specific radioactivity. In addition to this, the recovery of sphingosine in cultured neuronal cells (39) was also shown to occur proportionally to the cell ganglioside content. Thus it can be expected that the administration of [Neu5Ac-3H]GM3 or [Sph-3H]GM3 to cells will be followed by the incorporation of the catabolic radioactive sialic acid or sphingosine into the neobiosynthesized GM3 and GD3, the two main gangliosides of fibroblasts, in proportion to the endogenous ganglioside content (Table I). We calculated that after 72 h chase with [Neu5Ac-3H]GM3 neobiosynthetic gangliosides, glycoproteins, free sialic acid, and tritiated water, and with [Sph-3H]GM3 neobiosynthetic gangliosides, glycosphingolipids, ceramide, sphingomyelin, and tritiated water together cover about 50% of the total cell associated radioactivity.

From all these results it follows that at the end of the pulse-chase period with 4 × 10-7 M [Sph-3H]GM3, [Neu5Ac-3H]GM3, or [stearoyl-14C]GM3, half of the total associated radioactivity is still carried by the exogenously associated radioactive GM3. Thus we can predict, in agreement with previous suggestions (6), a ganglioside half-life of about 2-3 days.

The feeding experiments were also performed on fibroblasts from patients with Salla disease. This was done to evaluate the cell ganglioside processing in a system where the metabolic re-cycling of sialic acid is expected to be at least partially impaired.

The metabolic processing of [Neu5Ac-3H]GM3 taken up by both Salla fibroblast lines quickly produced, as expected, large amounts of free sialic acid. However, there was a reduced incorporation of [3H]Neu5Ac into both gangliosides and sialoglycoproteins, as compared to normal fibroblats. Furthermore, in spite of the large accumulation of free sialic acid only a very small part of it was catabolized to tritiated water. The lower degree of Neu5Ac salvage processes and the accumulation of free sialic acid appear to be an obvious consequence of the impaired exit of Neu5Ac from the pathological fibroblasts.

The activity of lysosomal glycosidases has been reported to be normal in Salla cells, although some results on the activity of sialidase seem controversial (7). In qualitative terms the metabolic processing of GM3 in normal and Salla cells appeared to be very similar. However, some steps of the lysosomal degradation of gangliosides in Salla cells seem to be slowed down. The small amount of radioactivity carried by neutral lipids following cell administration of [stearoyl-14C]GM3, with respect to that found after administration of [Sph-3H]GM3, suggests that these lipids are mainly intermediates of the ganglioside catabolism. LacCer and Cer were found to accumulate in Salla fibroblasts. This is an indication that some enzymes of glycosphingolipid metabolism are affected by a specific impairment of lysosomal function. Particularly relevant is the accumulation of ceramide which was hardly recognized in control cells. No data are available on the activity of ceramidase in Salla cells. The increase in ceramide, which has been described to be a highly bioactive intermediate of sphingolipid metabolisms (40), could be associated to some clinical features of the Salla pathology. Of course, this hypothesis calls for further experimental evidence.


FOOTNOTES

*   This work was supported in part by grants from the Consiglio Nazionale delle Ricerche (CNR), Italy (Grant 93.02246.PF39 Target Project ``ACRO''). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Dipartimento di Chimica e Biochimica Medica, Via Saldini 50, 20133 Milano, Italy. Fax: 3922363584; E-mail: sanson{at}imiucca.csi.unimi.it.
1   The ganglioside nomenclature is according to Svennerholm (41) and the IUPAC-IUB recommendations (42, 43).
2   The abbreviations used are: GM3, II3Neu5AcLacCer, alpha -Neu5Ac-(2-3)-beta -Gal-(1-4)-beta -Glc(1-1)-Cer; GD3, II3(Neu5Ac)2LacCer, alpha -Neu5Ac-(2-8)-alpha -Neu5Ac-(2-3)-beta -Gal-(1-4)-beta -Glc-(1-1)-Cer; LacCer, beta -Gal-(1-4)-beta -Glc-(1-1)-Cer; GlcCer, beta -Glc-(1-1)-Cer; Cer, ceramide; Neu5Ac, N-acetylneuraminic acid; Sph, sphingosine; SM, sphingomyelin; FCS, fetal calf serum.

Acknowledgment

We thank Professor Martin Renlund for providing Salla cell cultures and all the clinical information.


REFERENCES

  1. Wiegandt, H. (1985) New Compr. Biochem. 10, 199-266
  2. Schwarzmann, G., Sandhoff, K. (1990) Biochemistry 29, 10865-10871 [CrossRef][Medline] [Order article via Infotrieve]
  3. Radsak, G., Schwarzmann, G., Wiegandt, H. (1982) Hoppe Seyler's Z. Physiol. Chem. 363, 263-272 [Medline] [Order article via Infotrieve]
  4. Chigorno, V., Pitto, M., Cardace, G., Acquotti, D., Kirschner, G., Sonnino, S., Ghidoni, R., Tettamanti, G. (1985) Glycoconjugate J. 2, 279-291 [CrossRef]
  5. Riboni, L., Prinetti, A., Pitto, M., Tettamanti, G. (1990) Neurochem. Res. 15, 1175-1183 [CrossRef][Medline] [Order article via Infotrieve]
  6. Dawson, G., Matalon, R., Dorfman, A. (1972) J. Biol. Chem. 247, 5944-5950 [Abstract/Free Full Text]
  7. Gahl, W. A., Renlund, M., Thoene, J. G. (1989) The Metabolic Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., eds) , 6th Ed. , p. 2619, McGraw-Hill Book Company, New York
  8. Sonnino, S., Cantu', L., Acquotti, D., Corti, M., Tettamanti, G. (1990) Chem. Phys. Lipids 52, 231-241 [CrossRef][Medline] [Order article via Infotrieve]
  9. Hauttecoeur, B., Sonnino, S., Ghidoni, R. (1985) Biochim. Biophys. Acta 833, 303-307 [Medline] [Order article via Infotrieve]
  10. Ghidoni, R., Sonnino, S., Tettamanti, G., Wiegandt, H., Zambotti, V. (1976) J. Neurochem. 27, 511-515 [Medline] [Order article via Infotrieve]
  11. Riboni, L., Bassi, R., Sonnino, S., Tettamanti, G. (1992) FEBS Lett. 300, 188-192 [CrossRef][Medline] [Order article via Infotrieve]
  12. Sonnino, S., Kirschner, G., Ghidoni, R., Acquotti, D., Tettamanti, G. (1985) J. Lipid Res 26, 248-257 [Abstract]
  13. Negroni, E., Chigorno, V., Tettamanti, G., Sonnino, S. (1996) Glycoconjugate J. 13, 347-352 [CrossRef][Medline] [Order article via Infotrieve]
  14. Gazzotti, G., Sonnino, S., Ghidoni, R., Orlando, P., Tettamanti, G. (1984) Glycoconjugate J. 1, 111-121
  15. Leroy, J. G., Ho, W. M., McBrinn, M. C., Zielke, K., Jacob, J., O'Brien, J. S. (1972) Pediatr. Res. 6, 752-757
  16. Tettamanti, G., Bonali, F., Marchesini, S., Zambotti, V. (1973) Biochim. Biophys. Acta 296, 160-170 [Medline] [Order article via Infotrieve]
  17. Ledeen, R. W., Yu, R. K., Eng, L. F. (1973) J. Neurochem. 21, 829-839 [CrossRef][Medline] [Order article via Infotrieve]
  18. Sonnino, S., Chigorno, V., Acquotti, D., Pitto, M., Kirschner, G., Tettamanti, G. (1989) Biochemistry 28, 77-84 [CrossRef][Medline] [Order article via Infotrieve]
  19. Sonnino, S., Acquotti, D., Riboni, L., Giuliani, L., Kirschner, G., Tettamanti, G. (1986) Chem. Phys. Lipids 42, 3-26 [CrossRef][Medline] [Order article via Infotrieve]
  20. Valsecchi, M., Chigorno, V., Sonnino, S., Tettamanti, G. (1992) Chem. Phys. Lipids 60, 247-252 [CrossRef][Medline] [Order article via Infotrieve]
  21. Stahl, E. (1962) Dunnschicht Chromatographie , p. 498, Springer Verlag, Berlin
  22. Partridge, S. M. (1948) Biochem. J. 42, 238-248
  23. Vaskovsky, V. E., Kostetsky, E. Y. (1968) J. Lipid Res. 9, 396 [Abstract]
  24. Svennerholm, L. (1957) Biochim. Biophys. Acta 24, 604-611 [Medline] [Order article via Infotrieve]
  25. Miettinen, J., Takki-Lukkainen, J. T. (1959) Acta Chem. Scand. 13, 856-858
  26. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 [Free Full Text]
  27. Burton, K. (1956) Biochem. J. 62, 315-323 [Medline] [Order article via Infotrieve]
  28. Trinchera, M., Ghidoni, R., Sonnino, S., Tettamanti, G. (1990) Biochem. J. 270, 815-820 [Medline] [Order article via Infotrieve]
  29. Riboni, L., Bassi, R., Conti, M., Tettamanti, G. (1993) FEBS Lett. 322, 257-260 [CrossRef][Medline] [Order article via Infotrieve]
  30. Leon, A., Facci, L., Toffano, G., Sonnino, S., Tettamanti, G. (1981) J. Neurochem. 37, 350-357 [Medline] [Order article via Infotrieve]
  31. Saqr, H. E., Pearl, D. K., Yates, A. J. (1993) J. Neurochem. 61, 395-411 [Medline] [Order article via Infotrieve]
  32. Tomasi, M., Roda, G., Ausiello, C., D'Agnolo, G., Venerando, B., Ghidoni, R., Sonnino, S., Tettamanti, G. (1980) Eur. J. Biochem. 111, 315-324
  33. Venerando, B., Roberti, S., Sonnino, S., Fiorilli, A., Tettamanti, G. (1982) Biochim. Biophys. Acta 692, 18-26 [Medline] [Order article via Infotrieve]
  34. Schwarzmann, D., Marsh, D., Herzog, V. & Sandhoff, K. (1987) NATO ASI Ser. H7, 217-229
  35. Ghidoni, R., Sonnino, S., Chigorno, V., Venerando, B., Tettamanti, G. (1983) Biochem. J. 213, 321-329 [Medline] [Order article via Infotrieve]
  36. Hannun, Y. A., Bell, R. M. (1990) Science 243, 500-507
  37. Hancock, L. W., Horwitz, A. L., Dawson, G. (1983) Biochim. Biophys. Acta 760, 42-52 [Medline] [Order article via Infotrieve]
  38. Sonnino, S., Ghidoni, R., Fiorilli, A., Venerando, B. & Tettamanti, G. (1984) J. Neursci. Res. 12, 193-204
  39. van Echten, G., Birk, R., Brenner-Weiss, G., Schmidt, R. R., Sandhoff, K. (1990) J. Biol. Chem. 265, 9333-9339 [Abstract/Free Full Text]
  40. Okazaki, T., Bielawska, A., Bell, R. M., Hannun, Y. A. (1990) J. Biol. Chem. 265, 15823-15831 [Abstract/Free Full Text]
  41. Svennerholm, L. (1980) Adv. Exp. Biol. Med. 125, 11 [Medline] [Order article via Infotrieve]
  42. IUPAC-IUB Commission, Biochemical Nomenclature (1977) Lipids 12, 455-468 [Medline] [Order article via Infotrieve]
  43. IUB-IUPAC Joint Commission on Biochemical Nomenclature (JCBN) (1982) J. Biol. Chem. 257, 3347-3351

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
GlycobiologyHome page
B. Winchester
Lysosomal metabolism of glycoproteins
Glycobiology, June 1, 2005; 15(6): 1R - 15R.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hong and P. Stanley
Lec3 Chinese Hamster Ovary Mutants Lack UDP-N-acetylglucosamine 2-Epimerase Activity Because of Mutations in the Epimerase Domain of the Gne Gene
J. Biol. Chem., December 26, 2003; 278(52): 53045 - 53054.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. Hollister, H. Conradt, and D. L. Jarvis
Evidence for a sialic acid salvaging pathway in lepidopteran insect cells
Glycobiology, June 1, 2003; 13(6): 487 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Prinetti, L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al.
Altered Sphingolipid Metabolism in N-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells
J. Biol. Chem., February 14, 2003; 278(8): 5574 - 5583.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
O. T. Keppler, S. Hinderlich, J. Langner, R. Schwartz-Albiez, W. Reutter, and M. Pawlita
UDP-GlcNAc 2-Epimerase: A Regulator of Cell Surface Sialylation
Science, May 21, 1999; 284(5418): 1372 - 1376.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. Meivar-Levy, H. Sabanay, A. D. Bershadsky, and A. H. Futerman
The Role of Sphingolipids in the Maintenance of Fibroblast Morphology. THE INHIBITION OF PROTRUSIONAL ACTIVITY, CELL SPREADING, AND CYTOKINESIS INDUCED BY FUMONISIN B1 CAN BE REVERSED BY GANGLIOSIDE GM3
J. Biol. Chem., January 17, 1997; 272(3): 1558 - 1564.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow